Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Bankruptcy will not going to be announced by this CC. It has to wait until the next CC if the call ever happens. They will be filing for Ch 11 (or Ch 7) once the market cap drops to 10M. We are at 21M right now, so the share price has to drop to 1.40 area. Then, a bomb will be dropped.
My guess would be the following. After the CC, they'll try to issue few PRs regarding the clinical updates. The data will be not so impressive, and the stock will not move upwards. As few times before, the management will use these fluff PRs to pump the SP and do another raise. It will be the final raise at this point as the monetization of the platform has not happened. With the need to run 4 or 5 clinical trials and a lack of the funds to support these trials, the company will have no choice but to file for a bankruptcy as the cash burn will be too high. It's mind boggling that this company has been unable to sell anything -- not NEO, not HOT, not PSA, not AXAL. Why? The clinical data does seem to be just so-so, not too impressive to turn some corporate heads. Thus, the younger and more attractive companies and techs get taken out. Not us. We are as afterthought in the immuno oncology area.